Related Experiment Videos
Prostate cancer: experience with definitive irradiation in the aged
Urology
|March 1, 1985
Summary
For elderly patients with localized prostate cancer, age is a key factor in treatment decisions. Definitive irradiation can enhance quality of life and survival when carefully selected patients receive appropriate treatment.
Area of Science:
- Oncology
- Geriatric Medicine
- Radiation Oncology
Background:
- Localized prostate cancer treatment decisions traditionally rely on disease stage and grade.
- In elderly patients, chronological age significantly influences therapeutic choices.
- Balancing life expectancy with cancer's malignant potential is crucial for optimal outcomes.
Purpose of the Study:
- To evaluate the role and outcomes of definitive irradiation in elderly patients with localized prostate cancer.
- To assess the feasibility and efficacy of radiation therapy in a geriatric population.
- To review treatment experience in patients aged 73-90 years.
Main Methods:
- Retrospective review of 63 patients aged 73-90 years referred for irradiation.
- Patient selection criteria for definitive treatment were applied.
- Analysis of treatment outcomes focusing on quality of life and survival.
Main Results:
- 56 out of 63 patients (89%) were deemed medically suitable for definitive radiation therapy.
- Definitive irradiation was administered to selected elderly patients.
- Outcomes regarding quality of life and survival were assessed post-treatment.
Conclusions:
- Definitive irradiation is a viable therapeutic option for carefully selected elderly patients with localized prostate cancer.
- Appropriate patient selection and treatment details are essential for improving quality of life and survival in this demographic.
- Radiation therapy can be effectively utilized in geriatric oncology for prostate cancer management.